Search research articles
Contact Us
Filters
Showing results (811-820 of 903) with videos related to
Page
of 91
Sort By:
Oncotarget
|
April 8, 2011
Association of Mycoplasma hominis infection with prostate cancer
Yulia A Barykova, Denis Yu Logunov, Maxim M Shmarov, et al.
The Journal of Urology
|
April 8, 2020
Downgrading from Biopsy Grade Group 4 Prostate Cancer in Patients Undergoing Radical Prostatectomy for High or Very High Risk Prostate Cancer
Weranja Ranasinghe, Chad A Reichard, Yaw A Nyame, et al.
European Urology
|
October 11, 2014
Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy
John A Brockman, Shaheen Alanee, Andrew J Vickers, et al.
The American Journal of Tropical Medicine and Hygiene
|
September 12, 2022
Analysis of Zika Virus Sequence Data Associated with a School Cohort in Haiti
Md Mahbubul Alam, Carla Mavian, Bernard A Okech, et al.
Oncotarget
|
January 18, 2015
CD117⁺ cells in the circulation are predictive of advanced prostate cancer
Bethany A Kerr, Ranko Miocinovic, Armine K Smith, et al.
Cancer
|
November 14, 2018
Outcomes of very high-risk prostate cancer after radical prostatectomy: Validation study from 3 centers
Debasish Sundi, Jeffrey J Tosoian, Yaw A Nyame, et al.
The Journal of Urology
|
February 17, 2012
Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era
Adam S Kibel, Jay P Ciezki, Eric A Klein, et al.
Nature
|
November 18, 2021
Independent infections of porcine deltacoronavirus among Haitian children
John A Lednicky, Massimiliano S Tagliamonte, Sarah K White, et al.
Conservation Biology : the Journal of the Society for Conservation Biology
|
July 14, 2020
A strategy for the next decade to address data deficiency in neglected biodiversity
Axel Hochkirch, Michael J Samways, Justin Gerlach, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 16, 2012
A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer
H L Kindler, D A Richards, L E Garbo, et al.
Page
of 91
Search research articles
Search
Showing results (811-820 of 903) with videos related to
Sort By:
Page
of 91
Oncotarget
|
April 8, 2011
Association of Mycoplasma hominis infection with prostate cancer
Yulia A Barykova, Denis Yu Logunov, Maxim M Shmarov, et al.
The Journal of Urology
|
April 8, 2020
Downgrading from Biopsy Grade Group 4 Prostate Cancer in Patients Undergoing Radical Prostatectomy for High or Very High Risk Prostate Cancer
Weranja Ranasinghe, Chad A Reichard, Yaw A Nyame, et al.
European Urology
|
October 11, 2014
Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy
John A Brockman, Shaheen Alanee, Andrew J Vickers, et al.
The American Journal of Tropical Medicine and Hygiene
|
September 12, 2022
Analysis of Zika Virus Sequence Data Associated with a School Cohort in Haiti
Md Mahbubul Alam, Carla Mavian, Bernard A Okech, et al.
Oncotarget
|
January 18, 2015
CD117⁺ cells in the circulation are predictive of advanced prostate cancer
Bethany A Kerr, Ranko Miocinovic, Armine K Smith, et al.
Cancer
|
November 14, 2018
Outcomes of very high-risk prostate cancer after radical prostatectomy: Validation study from 3 centers
Debasish Sundi, Jeffrey J Tosoian, Yaw A Nyame, et al.
The Journal of Urology
|
February 17, 2012
Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era
Adam S Kibel, Jay P Ciezki, Eric A Klein, et al.
Nature
|
November 18, 2021
Independent infections of porcine deltacoronavirus among Haitian children
John A Lednicky, Massimiliano S Tagliamonte, Sarah K White, et al.
Conservation Biology : the Journal of the Society for Conservation Biology
|
July 14, 2020
A strategy for the next decade to address data deficiency in neglected biodiversity
Axel Hochkirch, Michael J Samways, Justin Gerlach, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 16, 2012
A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer
H L Kindler, D A Richards, L E Garbo, et al.
Page
of 91